NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025

Core Viewpoint - NanoViricides, Inc. is set to present its innovative antiviral drug developments at the LSX World Congress 2025 in Boston on September 17, 2025, highlighting its position as a leader in the clinical stage of broad-spectrum antiviral drugs that are designed to be escape-proof against viruses [1]. Company Summary - The company is focused on developing revolutionary antiviral drugs that target a wide range of viruses [1]. - The presentation will take place at 12:30 pm at the LSX Biotech ShowCase, part of the Life Science Executive Partnering World Congress [1]. Event Details - The event is scheduled for Wednesday, September 17, 2025, at the Thomas Michael Menino Convention and Exhibition Center in Boston, MA [1]. - This presentation is part of a significant industry event, indicating the company's active engagement in the biotech sector [1].